The antidepression drug duloxetine could be beneficial to patients with both depression and cardiovascular disease, according to new studies performed in human blood and in mice. Globally, more than 300 million people have ...
Apr 27, 2021
0
9
Cardiovascular disease, the most common cause of death, is the result of oxygen deprivation as blood perfusion to affected tissue is prevented. To halt the development of the disease and to promote healing, re-establishment ...
Apr 23, 2021
0
5
I have high cholesterol, but I can't take statin drugs. Are there any new medications that I should consider?
Feb 16, 2021
0
4
Recreational drinking, smoking, and drug use is linked to premature heart disease in young people, particularly younger women, finds research published online in the journal Heart.
Feb 15, 2021
0
49
Less than a decade ago, the Food and Drug Administration approved drugs for treating type 2 diabetes in an entirely new way. Since that time, evidence in favor of the use of sodium/glucose cotransporter 2 (SGLT2) inhibitors ...
Nov 17, 2020
0
18
The relationship between dietary habits and the occurrence of chronic kidney disease (CKD) is not fully known. In a new study, researchers from Kanazawa University found out that skipping breakfast and late dinner might be ...
Nov 9, 2020
0
47
Cardiovascular disease is the leading cause of death worldwide, killing nearly 18 million people annually, which is approximately the entire population of the New York metropolitan area. Now, researchers at the University ...
Aug 25, 2020
0
3
A new Northwestern Medicine study in mice found a widely used class of drugs to treat patients with hypertension, cardiovascular disease and diabetic kidney disease—many of whom are elderly—does not increase the risk ...
Jul 22, 2020
0
0
Hydroxychloroquine and azithromycin may have a serious impact on the cardiovascular system and are a potentially lethal combination, according to a large analysis of a World Health Organization (WHO) database on adverse drug ...
May 25, 2020
0
163
The U.S. Food and Drug Administration has granted approval for Farxiga (dapagliflozin) oral tablets to treat adults with heart failure with reduced ejection fraction, the agency announced Tuesday.
May 7, 2020
0
1
